Skip to main content
OpenTrials

Clinical trial condition

Endometrial Neoplasms

Explore clinical trials studying Endometrial Neoplasms. Study availability and eligibility vary by location and protocol.

77 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Endometrial Neoplasms trial results

Completed

Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001)

NCT03884101

Conditions
Endometrial Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • University of South Alabama, Mitchell Cancer Institute ( Site 0245) Mobile, Alabama, United States
  • Arizona Oncology Associates PC- HOPE ( Site 8005) Tucson, Arizona, United States
  • UCLA Hematology and Oncology Clinic (Westwood) ( Site 0233) Los Angeles, California, United States
  • University of Colorado Cancer Center ( Site 0204) Aurora, Colorado, United States
View all 195 locations
View Trial Details
Completed

Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001) - China Extension Study

NCT04865289

Conditions
Endometrial Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Anhui Cancer Hospital-Gynecological Oncology ( Site 2509) Hefei, Anhui, China
  • Beijing Obstetrics and Gynecology Hospital Capital Medical University ( Site 2505) Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital ( Site 2501) Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital ( Site 2504) Beijing, Beijing Municipality, China
View all 22 locations
View Trial Details
Completed

MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)

NCT05007106

Conditions
Adenocarcinoma, Adnexal Diseases, Biliary Tract Diseases, +52 more
Locations
  • Alaska Womens Cancer Care ( Site 1016) Anchorage, Alaska, United States
  • City of Hope Comprehensive Cancer Center ( Site 1001) Duarte, California, United States
  • University of California, Irvine (UCI) Health - UC Irvine Me-Chao Family Comprehensive Cancer Cente Orange, California, United States
  • Karmanos Cancer Institute ( Site 1007) Detroit, Michigan, United States
View all 73 locations
View Trial Details
Completed

COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors.

NCT04570839

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +19 more
Locations
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Johns Hopkins University Oncology Center. Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • START Midwest. Grand Rapids, Michigan, United States
View Trial Details

Related conditions